A lack of association between adiponectin polymorphisms and coronary artery disease in a Chinese population

Genetics and Molecular Biology

Volumn 33, Issue 3, 2010, Pages 428-433

  Zhong, Chen ^a   Zhen, Ding ^a   Qi, Qian ^a   Genshan, Ma ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Adiponectin gene; Coronary artery disease; Single nucleotide polymorphisms

Indexed keywords

ADIPONECTIN;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; HEART INFARCTION; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77957309686     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572010005000064     Document Type: Article

References (36)

1. Antoniades C, Antonopoulos AS, Tousoulis D and Stefanadis C (2009) Adiponectin: From obesity to cardiovascular disease. Obes Rev 10:269-279.
2. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD and Kahn SE (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex. Diabetologia 46:459-469.
3. Favis R, Day JP, Gerry NP, Phelan C, Narod S and Barany F (2000) Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat Biotechnol 18:561-564.
4. Filippi E, Sentinelli F, Trischitta V, Romeo S, Arca M, Leonetti F, Di Mario U and Baroni MG (2004) Association of the human adiponectin gene and insulin resistance. Eur J Hum Genet 12:199-205.
5. Filippi E, Sentinelli F, Romeo S, Arca M, Berni A, Tiberti C, Verrienti A, Fanelli M, Fallarino M, Sorropago G, et al. (2005) The adiponectin gene SNP+276G > T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age ≤ 50 years). J Mol Med 83:711-719.
6. Fisher FF, Trujillo ME, Hanif W, Barnett AH, McTernan PG, Scherer PE and Kumar S (2005) Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia 48:1084-1087.
7. Gui MH, Hong J, Lü AK, Chen Y, Shen WF, Li XY and Ning G (2008) High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status. Chin Med J (Engl) 121:2509-2516.
8. Haluzík M, Parízková J and Haluzík MM(2004) Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 53:123-129.
9. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K et al. (2002) Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51:536-540.
10. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP et al. (2005) Major causes of death among men and women in China. N Engl J Med 353:1124-1134.
11. Kadowaki T and Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439-451.
12. Karakas M, Zierer A, Herder C, Baumert J, Meisinger C, Koenig W and Thorand B (2010) Leptin, adiponectin, their ratio and risk of coronary heart disease: Results from the MONICA/KORA Augsburg Study 1984-2002. Atherosclerosis 209:220-225.
13. Kawano J and Arora R (2009) The role of adiponectin in obesity, diabetes, and cardiovascular disease. J Cardiometab Syndr 4:44-49.
14. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H et al. (2002) Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277:25863-25866.
15. Kuller LH, Grandits G, Cohen JD, Neaton JD and Prineas R (2007) Multiple Risk Factor Intervention Trial Research Group. Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome. Atherosclerosis 195:122-128.
16. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H et al. (2003) Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23:85-89.
17. Matsubara M, Maruoka S and Katayose S (2002) Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87:2764-2769.
18. Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE, Trischitta V and Doria A (2002) A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51:2306-2312.
19. Menzaghi C, Trischitta V and Doria A (2007) Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 56:1198-1209.
20. Otsuka F, Sugiyama S, Kojima S, Maruyoshi H, Funahashi T, Matsui K, Sakamoto T, Yoshimura M, Kimura K, Umemura S et al. (2006) Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. J Am Coll Cardiol 48:1155-1162.
21. Otsuka F, Sugiyama S, Kojima S, Maruyoshi H, Funahashi T, Sakamoto T, Yoshimura M, Kimura K, Umemura S and Ogawa H (2007) Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men. Circ J 71:1703-1709.
22. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T et al. (1999) Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 100:2473-2476.
23. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M et al. (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMPdependent pathway. Circulation 102:1296-1301.
24. Pischon T, Pai JK, Manson JE, Hu FB, Rexrode KM, Hunter D and Rimm EB (2007) Single nucleotide polymorphisms at the adiponectin locus and risk of coronary heart disease in men and women. Obesity 15:2051-2060.
25. Rizza S, Clementi F, Porzio O, Cardellini M, Savo A, Serino M, Chiricolo G, Romeo F, Lauro R and Federici M (2009) Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD. Nutr Metab Cardiovasc Dis 19:54-60.
26. Rothenbacher D, Brenner H, März W and Koenig W (2005) Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J 26:1640-1646.
27. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y and Funahashi T (2004) Adiponectin as a biomarker of the metabolic syndrome. Circ J 68:975-981.
28. Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM, Danesh J and Whincup PH (2006) Adiponectin and coronary heart disease: A prospective study and meta-analysis. Circulation 114:623-629.
29. Selcuk MT, Selcuk H, Temizhan A, Maden O, Saydam GS, Dogan M, Ulupinar H, Aydin C, Topcu DI and Sasmaz A (2008) Impact of plasma adiponectin levels to the presence and severity of coronary artery disease in patients with metabolic syndrome. Coron Artery Dis 19:79-84.
30. Tilg H and Moschen AR (2008) Role of adiponectin and PBEF/visfatin as regulators of inflammation: Involvement in obesity-associated diseases. Clin Sci (Lond) 114:275-288.
31. Trujillo ME and Scherer PE (2005) Adiponectin - Journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257:167-175.
32. von Eynatten M, Hamann A, Twardella D, Nawroth PP, Brenner H and Rothenbacher D (2006) Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin Chem 52:853-859.
33. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H and Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-1847.
34. Xiao Z, Xiao J, Jiang Y, Zhang S, Yu M, Zhao J, Wei D and Cao H (2006) A novel method based on ligase detection reaction for low abundant YIDD mutants detection in hepatitis B virus. Hepatol Res 34:150-155.
35. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J et al. (2003) Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278:2461-2468.
36. Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME, Yashin AI and De Faire U (2002) Heritability of death from coronary heart disease: A 36-year follow-up of 20,966 Swedish twins. J Intern Med 252:247-254.